Mylan N.V. (MYL) EPS & PE Ratio History
Current and historical earning per share (EPS) and price to earnings (PE) ratio for Mylan N.V. (MYL) over the last 10 years. The current PE ratio for Mylan N.V. as of November 22, 2017 is 7.93.
|Medical||Medical - Generic Drugs||$19.998B||$11.077B|
|Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.|